2013 annual financial data
Viridian Therapeutics 2013 Operating margin
Direct answer
Operating margin was -4.55%.
Operating income was -196,213 USD and net income was -2.16M USD.
Operating cash flow was -1.17M USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4.32M USD
- Operating income
- -196,213 USD
- Net income
- -2.16M USD
- Operating cash flow
- -1.17M USD